Analysts See Risks To EPS Upside From CBOE-Bats Deal


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Goldman Sachs sees risks to EPS upside from CBOE Holdings, Inc (NASDAQ: CBOE)'s $3.2 billion acquisition of Bats Global Markets Inc (BATS:BATS) from potential P/E de-rating.

"Our hypothetical pro forma analysis suggests a potential deal would result in $3.41- 3.52 in adjusted EPS for CBOE for 2018, or 22%-26% accretion vs. GSe and 17%-20% to cons. estimate," analyst Alexander Blostein wrote in a note.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

"At the same time we see risk that a change in CBOE's product mix (away from higher multiple Index Options/Futures and toward cash equities and multi-listed options) and potentially higher leverage (current CBOE is debt free) could result in a 21%-32% P/E de-rating for the stock based on public comps with similar revenue mix," Blostein continued.

Further, the analyst expects pressure on the multiple as the deal may be a signal of "(1) limited EPS growth at CBOE (consensus implies flat EPS for 2016) and (2) risks from rising competition in the multi-listed options space (from BATS and NDAQ/ISE."

Blostein reiterated his Sell rating on CBOE with price target of $61.

Shares of CBOE traded recently at $67.01.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorNewsReiterationM&AAnalyst RatingsAlexander BlosteinGoldman Sachs